Vimta Labs Share Price

Vimta Labs Share Price

NSE: VIMTALABS
|
Pharmaceuticals
₹ 570.45
+₹6.95 (1.23%)
1D
Last updated 24 Jul, 2026, 15:57 IST

Vimta Labs Share Price Today

As of 25 Jul 2026, Vimta Labs share price is ₹570.45. The stock opened at ₹563.50, compared to its previous close of ₹563.50. During today's trading session, Vimta Labs share price moved in the range of ₹553.00 to ₹574.80, with an average price of ₹563.90 for the day. Looking at its last 52-week, the stock has touched a low of ₹376.05 and a high of ₹902.65. On the performance front, Vimta Labs share price has increased by 10.84% over the last six months and is up 12.75% on a year-on-year basis.


₹553.00
1.23% up today
₹574.80
1D LOW
1D HIGH

Vimta Labs Returns Calculator


Circuit
L
H
₹456.40
₹684.50
52-week
L
H
₹376.05
₹902.65
Mkt Cap Cr
2,137.65

P/E
34.83

P/B
6.24

ROE
14.59%

D/E
0.01

ROCE
19.04%

Div. Yield
0.35%

EPS(TTM)
17.40
Turnover
0.74

EV/EBITDA
18.28

Net Margin
19.03%

Op. Margin
36.56%

ROA
13.94%

Quick Ratio
2.97

Curr. Ratio
3.53
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Vimta Labs has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Vimta Labs appears overvalued compared to its peers
Step 3 of 5
Earnings
Neutral
Vimta Labs earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Apollo Hospitals1,26,592.0063.7613.4820.48%0.3217.27%692.920.23%0.70103.81
Max Healthcare1,05,256.0064.898.7114.33%0.0813.72%10.470.21%0.287.37
Fortis Healthcare71,354.9057.586.0611.31%0.2213.36%6.500.13%0.163.05
Aster DM Healthcare68,387.10160.0014.928.48%0.3110.10%53.530.23%0.465.20
Narayana Hrudayalaya40,457.3050.208.9217.76%0.7611.42%127.100.23%0.8524.77
Global Health36,944.3066.679.3314.05%0.0615.26%149.240.04%0.7718.46
KRISHNA INST OF MED SCI L32,838.20138.418.9410.74%0.637.99%93.540.00%0.466.52
Dr. Lal Path Labs28,275.5043.618.7821.78%0.0727.45%8.901.56%1.0130.45
Poly Medicure16,538.8051.575.3210.37%0.0812.71%301.180.21%0.5333.15
Syngene International16,265.8049.653.257.78%0.059.52%3.340.32%0.677.58

Vimta Labs Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2024Mar 2023Mar 2022Mar 2021
Revenue₹318.26₹318.19₹278.28₹210.68
Other Income₹4.01₹3.44₹1.45₹0.83
Total Revenue₹322.27₹321.63₹279.73₹211.51
Total Expenses₹267.79₹256.64₹222.82₹182.97
Profit Before Tax₹54.48₹65.00₹55.69₹28.54
Tax₹13.47₹16.83₹14.36₹7.14
Profit After Tax₹41.01₹48.17₹41.33₹21.41
EPS - Basic₹18.51₹21.77₹18.70₹9.68
EPS - Diluted₹18.24₹21.35₹18.32₹9.68

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2024Mar 2023Mar 2022Mar 2021
Profit before tax₹54.48₹65.00₹55.69₹28.54
Income before WC changes₹91.75₹104.11₹87.07₹57.77
Change in Assets-₹11.53-₹15.46-₹15.26-₹19.81
Change in Liabilities-₹3.85₹11.82₹3.90₹6.43
Change in WC-₹15.38-₹3.64-₹11.36-₹13.38
Cash flow from Operations₹60.89₹87.94₹59.07₹37.18
Cash flow from Investing-₹76.05-₹57.26-₹37.85-₹31.92
Cash flow from Financing-₹1.90-₹10.98-₹16.61-₹4.57
Total Cash Flow-₹17.06₹19.70₹4.61₹0.69
Cash (Start of the year)₹30.50₹10.80₹6.19₹5.51
Cash (End of the year)₹13.44₹30.50₹10.80₹6.19

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2024Mar 2023Mar 2022Mar 2021
Non-Current Assets₹242.45₹198.67₹182.84₹163.82
Current Assets₹157.60₹163.66₹124.36₹110.54
Total Assets₹400.05₹362.33₹307.20₹274.36
Current Liabilities₹54.07₹57.28₹47.75₹53.91
Net Current Asset₹103.53₹106.38₹76.61₹56.63
Non-Current Liabilities₹26.28₹23.26₹25.47₹26.06
Equity Capital₹319.70₹281.79₹233.98₹194.38
Total Equity & Liabilities₹400.05₹362.33₹307.20₹274.36

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹407.29₹343.98₹288.60₹315.12
Other Income₹8.99₹4.24₹3.71₹3.47
Total Revenue₹416.28₹348.22₹292.31₹318.58
Total Expenses₹310.71₹259.22₹229.80₹254.75
Profit Before Tax₹103.95₹89.00₹62.50₹63.83
Tax₹26.44₹22.25₹13.69₹16.53
Profit After Tax₹77.51₹66.76₹48.81₹47.30
EPS - Basic₹17.40₹30.28₹18.51₹21.37
EPS - Diluted₹17.20₹29.86₹18.24₹20.96

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹103.95₹90.41₹54.48₹63.83
Income before WC changes₹154.65₹124.06₹91.75₹102.74
Change in Assets-₹7.75-₹25.01-₹11.53-₹15.45
Change in Liabilities₹23.91₹17.02-₹3.85₹11.45
Change in WC₹16.16-₹7.99-₹15.38-₹3.99
Cash flow from Operations₹147.14₹94.05₹60.89₹86.51
Cash flow from Investing-₹129.67-₹75.54-₹76.05-₹56.93
Cash flow from Financing-₹10.35-₹16.12-₹1.90-₹10.66
Total Cash Flow₹7.12₹2.40-₹17.06₹18.92
Cash (Start of the year)₹15.84₹13.44₹30.50₹10.65
Cash (End of the year)₹22.97₹15.84₹13.44₹29.57

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹337.36₹278.72₹236.87₹197.69
Current Assets₹224.87₹187.82₹157.60₹162.78
Total Assets₹562.23₹466.53₹394.47₹360.47
Current Liabilities₹65.52₹64.37₹54.07₹56.74
Net Current Asset₹159.35₹123.45₹103.53₹106.03
Non-Current Liabilities₹39.83₹23.32₹26.28₹23.15
Equity Capital₹456.87₹378.85₹314.12₹280.58
Total Equity & Liabilities₹562.23₹466.53₹394.47₹360.47
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
570.45
40
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 40
Buy orders: 0%
Sell orders: 100%
Bearish
1
Neutral
6
Bullish
1
Neutral
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict

RSI (14)
52.95
Neutral

ATR (14)
32.5
Neutral

STOCH(9,6)
40.75
Neutral

STOCH RSI (14)
56.16
Neutral

ADX(9)
24.61
Bearish

UO(9)
40.86
Neutral

ROC(12)
6.04
Bullish

WillR(14)
-59.25
Neutral
Period
Simple value
Exponential vaue

5D
569.54
570

10D
565.35
567.88

20D
568.1
563.69

50D
532.4
540.57

100D
490.44
524.41

About Vimta Labs

Vimta Labs Share Price
ISIN
INE579C01029
Sector Market Cap
₹ 2,137.65 Cr

Vimta Labs Limited is contract research and testing services provider in India. The Company operates through the Contract Research and Testing Services segment. It is engaged in providing a range of services to biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device, power, cement, oil and gas, ores and minerals, infrastructure and many other industries, government organizations as well as other industry participants. Its services include drug discovery, development, and drug life cycle management support services; preclinical research and testing services for medical device companies; contract research and testing for agrochemical and specialty chemical companies; food testing and analytical development services to support manufacturers, processors, farmers, and retailers; and environmental regulatory services, such as impact assessments and post project monitoring to various industries, such as power, infrastructure, and others.

Vimta Labs Financial Highlights

  • Revenue: Vimta Labs reported revenue of ₹292.31 crore in FY24 vs ₹321.63 crore in FY23. It showed a decrease of 9.12% on a yearly basis.
  • Operating Profit: Vimta Labs reported an operating profit of ₹62.50 crore in FY24 vs ₹65.00 crore in FY23. It showed a decrease of 3.85% on a year-on-year basis.
  • Net Profit: Vimta Labs reported a net profit of ₹41.01 crore in FY24 vs ₹48.17 crore in FY23. It showed a decrease of 14.86% on a yearly basis.

Vimta Labs Quarterly Result Highlights

  • Vimta Labs reported revenue of ₹91.15 crore in Dec 2024, compared with ₹85.42 crore in Sep 2024, representing an increase of 6.71% on a quarter-on-quarter (QoQ) basis.
  • Vimta Labs reported an operating profit of ₹23.92 crore in Dec 2024, compared with ₹21.89 crore in Sep 2024, representing an increase of 9.27% on a quarter-on-quarter (QoQ) basis.
  • Vimta Labs reported a profit of ₹21.50 crore in Dec 2024, compared with ₹15.25 crore in Sep 2024, reflecting an increase of 40.98% on a QoQ basis.
  • The earnings per share (EPS) of Vimta Labs stood at ₹18.51 during Dec 2024.
Know more
Promoters
35.67%
FII
4.42%
Other DII
0.17%
Retail and other
59.55%
Mutual funds
0.20%
Foreign institutions - FII
Compare against other stocks
Vimta Labs Share Price
Vimta Labs
Pharmaceuticals
Add Stock
Add Another

FAQs on Vimta Labs Share Price